Probiotic containing <i>Lactobacillus reuteri DSM 17648</i> as an adjunct treatment for <i>Helicobacter pylori</i> infection: A randomized, double‐blind, placebo‐controlled trial

Abstract

There was a significant increase in H. pylori eradication rate and attenuation of symptoms and adverse treatment effects when L. reuteri was given as an adjunct treatment.